Cwm LLC Buys 18,960 Shares of Veeva Systems Inc. $VEEV

Key Points

• Cwm LLC increased its stake in Veeva Systems by 215.8%, purchasing an additional 18,960 shares, with total holdings now valued at approximately $7,990,000.
• A variety of analysts have raised their target prices for Veeva Systems, with estimates now ranging from $300.00 to $355.00, reflecting a consensus rating of "Moderate Buy".
• Insider transactions have occurred recently, with senior vice president Jonathan Faddis selling 720 shares and Eleni Nitsa Zuppas selling 6,000 shares, leading to a notable decrease in their respective ownership positions.

Cwm LLC lifted its stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 215.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 27,745 shares of the technology company's stock after purchasing an additional 18,960 shares during the period. Cwm LLC's holdings in Veeva Systems were worth $7,990,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Abound Financial LLC acquired a new position in shares of Veeva Systems during the 1st quarter worth approximately $25,000. ORG Partners LLC acquired a new position in shares of Veeva Systems during the 1st quarter worth approximately $26,000. Trust Co. of Toledo NA OH acquired a new position in shares of Veeva Systems during the 2nd quarter worth approximately $29,000. Golden State Wealth Management LLC increased its holdings in shares of Veeva Systems by 152.9% during the 1st quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company's stock worth $30,000 after acquiring an additional 78 shares during the last quarter. Finally, Wayfinding Financial LLC acquired a new position in shares of Veeva Systems during the 1st quarter worth approximately $32,000. Institutional investors own 88.20% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on VEEV shares. Canaccord Genuity Group boosted their target price on Veeva Systems from $270.00 to $300.00 and gave the stock a "hold" rating in a report on Thursday, August 28th. Needham & Company LLC boosted their target price on Veeva Systems from $300.00 to $355.00 and gave the stock a "buy" rating in a report on Thursday, August 28th. Stifel Nicolaus boosted their target price on Veeva Systems from $295.00 to $320.00 and gave the stock a "buy" rating in a report on Thursday, August 28th. Piper Sandler boosted their target price on Veeva Systems from $325.00 to $355.00 and gave the stock an "overweight" rating in a report on Thursday, August 28th. Finally, Mizuho boosted their target price on Veeva Systems from $295.00 to $325.00 and gave the stock an "outperform" rating in a report on Friday, August 29th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $307.58.

Insider Transactions at Veeva Systems

In other news, SVP Jonathan Faddis sold 720 shares of the stock in a transaction on Monday, October 6th. The stock was sold at an average price of $298.12, for a total transaction of $214,646.40. Following the sale, the senior vice president directly owned 7,868 shares of the company's stock, valued at approximately $2,345,608.16. This represents a 8.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the sale, the insider directly owned 25,325 shares in the company, valued at approximately $7,765,151.50. This trade represents a 19.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 24,665 shares of company stock valued at $7,438,000. 10.30% of the stock is owned by corporate insiders.

Veeva Systems Price Performance

VEEV stock opened at $287.81 on Wednesday. The stock has a market capitalization of $47.17 billion, a price-to-earnings ratio of 59.10, a PEG ratio of 2.21 and a beta of 0.98. The business's fifty day moving average price is $283.06 and its two-hundred day moving average price is $265.77. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.90 by ($0.64). The firm had revenue of $789.08 million for the quarter, compared to the consensus estimate of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm's quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Research analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.